2025年12月27日结束的Cogent生物科学股份监管协议允许内幕人士自由出售股票。 A lock-up agreement for Cogent Biosciences shares ends on Dec. 27, 2025, allowing insiders to sell stock freely.

在从2025年11月11日起实行45至46天的限制之后,2025年12月27日终止了Cogent Biosciences股份(涉及董事、经理和某些股东)的扣押协议。 A lock-up agreement for Cogent Biosciences, Inc. shares, affecting directors, executives, and certain shareholders, ends on December 27, 2025, following a 45- to 46-day restriction starting November 11, 2025. 该协定禁止在未经承保人批准的情况下出售、转让或认捐共同股票或可兑换证券,以稳定股票交易后的状况。 The agreement prohibits selling, transferring, or pledging common stock or convertible securities without underwriter approval, aiming to stabilize the stock post-offering. 除少数例外情况外,这项限制适用于限制性库存单位、共同股份和股票选择权。 The restriction applies to restricted stock units, common shares, and stock options, with limited exceptions. 2025年12月27日之后,这些股份可以自由交易。 After December 27, 2025, these shares may be traded freely.